Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 177 of 1,261
  1. US 11725060

    Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

    Aptevo Research and Development LLC · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  2. US 11725054

    Anti-CD83 antibodies and use thereof

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  3. US 11725043

    Ulinastatin polypeptides

    DiaMedica USA Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  4. US 11725039

    α/β t-cell receptor and methods of using it

    University College Cardiff Consultants Limited · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  5. US 11725024

    Antibody drug conjugates

    Takeda Pharmaceutical Company Limited · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  6. US 11724987

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  7. US 11723873

    Oral dosage form of ticagrelor and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  8. US 11723992

    Method for extraction and purification of 68GA

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  9. US 11723982

    Methods of treating an ocular disease or disorder

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  10. US 11723952

    Methods and compositions for treating Huntington's Disease

    Sangamo Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  11. US 11723949

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  12. US 11723943

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  13. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  14. US 11723864

    Antimicrobial and anti-inflammatory compositions

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  15. US 11723980

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  16. US 11723959

    Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide

    HALOZYME, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  17. US 11723362

    Broad-spectrum synergistic antimicrobial compositions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  18. US 11723885

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  19. US 11723762

    LIDAR based 3-D imaging with far-field illumination overlap

    VELODYNE LIDAR, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  20. US 11725005

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  21. US 11725034

    IL2 agonists and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  22. US 11723946

    Methods for regulating transcription of multiple genes and expression of multiple targets

    China Medical University · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  23. US 11723900

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  24. US 11723990

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.